KR101684292B1 - 폴리펩티드 및 그람 양성 폴리펩티드를 함유하는 면역 조성물 및 사용 방법 - Google Patents

폴리펩티드 및 그람 양성 폴리펩티드를 함유하는 면역 조성물 및 사용 방법 Download PDF

Info

Publication number
KR101684292B1
KR101684292B1 KR1020157018079A KR20157018079A KR101684292B1 KR 101684292 B1 KR101684292 B1 KR 101684292B1 KR 1020157018079 A KR1020157018079 A KR 1020157018079A KR 20157018079 A KR20157018079 A KR 20157018079A KR 101684292 B1 KR101684292 B1 KR 101684292B1
Authority
KR
South Korea
Prior art keywords
seq
polypeptide
amino acid
kda
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020157018079A
Other languages
English (en)
Korean (ko)
Other versions
KR20150093774A (ko
Inventor
리사 엘. 헤론-올슨
드류 엠. 카트론
Original Assignee
이피토픽스, 엘엘씨
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 이피토픽스, 엘엘씨 filed Critical 이피토픽스, 엘엘씨
Publication of KR20150093774A publication Critical patent/KR20150093774A/ko
Application granted granted Critical
Publication of KR101684292B1 publication Critical patent/KR101684292B1/ko
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/085—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/38—Antigens from snakes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
KR1020157018079A 2009-03-23 2010-03-23 폴리펩티드 및 그람 양성 폴리펩티드를 함유하는 면역 조성물 및 사용 방법 Expired - Fee Related KR101684292B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21077209P 2009-03-23 2009-03-23
US61/210,772 2009-03-23
PCT/US2010/028326 WO2010111273A1 (en) 2009-03-23 2010-03-23 Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020117025065A Division KR20120005471A (ko) 2009-03-23 2010-03-23 폴리펩티드 및 그람 양성 폴리펩티드를 함유하는 면역 조성물 및 사용 방법

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020167026534A Division KR20160114744A (ko) 2009-03-23 2010-03-23 폴리펩티드 및 그람 양성 폴리펩티드를 함유하는 면역 조성물 및 사용 방법

Publications (2)

Publication Number Publication Date
KR20150093774A KR20150093774A (ko) 2015-08-18
KR101684292B1 true KR101684292B1 (ko) 2016-12-08

Family

ID=42781438

Family Applications (4)

Application Number Title Priority Date Filing Date
KR1020117025065A Ceased KR20120005471A (ko) 2009-03-23 2010-03-23 폴리펩티드 및 그람 양성 폴리펩티드를 함유하는 면역 조성물 및 사용 방법
KR1020167026534A Ceased KR20160114744A (ko) 2009-03-23 2010-03-23 폴리펩티드 및 그람 양성 폴리펩티드를 함유하는 면역 조성물 및 사용 방법
KR1020167013476A Expired - Fee Related KR101770321B1 (ko) 2009-03-23 2010-03-23 폴리펩티드 및 그람 양성 폴리펩티드를 함유하는 면역 조성물 및 사용 방법
KR1020157018079A Expired - Fee Related KR101684292B1 (ko) 2009-03-23 2010-03-23 폴리펩티드 및 그람 양성 폴리펩티드를 함유하는 면역 조성물 및 사용 방법

Family Applications Before (3)

Application Number Title Priority Date Filing Date
KR1020117025065A Ceased KR20120005471A (ko) 2009-03-23 2010-03-23 폴리펩티드 및 그람 양성 폴리펩티드를 함유하는 면역 조성물 및 사용 방법
KR1020167026534A Ceased KR20160114744A (ko) 2009-03-23 2010-03-23 폴리펩티드 및 그람 양성 폴리펩티드를 함유하는 면역 조성물 및 사용 방법
KR1020167013476A Expired - Fee Related KR101770321B1 (ko) 2009-03-23 2010-03-23 폴리펩티드 및 그람 양성 폴리펩티드를 함유하는 면역 조성물 및 사용 방법

Country Status (14)

Country Link
US (2) US9932373B2 (enExample)
EP (1) EP2411046B1 (enExample)
JP (2) JP2012521441A (enExample)
KR (4) KR20120005471A (enExample)
CN (1) CN105582524A (enExample)
AR (1) AR075933A1 (enExample)
AU (1) AU2016201992B2 (enExample)
BR (1) BRPI1011856A2 (enExample)
CA (1) CA2756313A1 (enExample)
IL (2) IL215330A (enExample)
MX (1) MX339461B (enExample)
NZ (2) NZ595231A (enExample)
WO (1) WO2010111273A1 (enExample)
ZA (1) ZA201106959B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101119744B (zh) 2005-02-14 2013-03-13 埃皮托皮克斯有限责任公司 来自金黄色葡萄球菌的多肽和使用方法
BRPI1011856A2 (pt) 2009-03-23 2020-11-03 Epitopix, Llc polipeptídeos e composições de imunização contendo polipeptídeos gram-positivos e métodos de uso
AU2013202253B2 (en) * 2009-04-14 2015-03-19 Novartis Ag Compositions for immunising against Staphylococcus aureus
US9724658B2 (en) * 2011-03-28 2017-08-08 Fast & Fluid Management B.V. Method of homogenizing a liquid
US8753643B1 (en) 2012-04-11 2014-06-17 Life-Science Innovations, Llc Spray dried compositions and methods of use
US20170023569A1 (en) * 2014-01-10 2017-01-26 University Of Rochester Diagnostic device and method for detection of staphylococcus infection
WO2017011340A2 (en) * 2015-07-10 2017-01-19 Epitopix, Llc. Proteins and immunizing compositions containing klebsiella proteins and methods of use
US11324815B2 (en) 2016-10-21 2022-05-10 Socpra—Sciences et Genie, S.E.C. Vaccine constructs and uses thereof against Staphylococcus infections

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060115490A1 (en) 2001-03-27 2006-06-01 Vega Masignani Staphylococcus aureus proteins and nucleic acids
US20080200650A1 (en) 2005-02-14 2008-08-21 Epitopix, Llc Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4981685A (en) 1986-03-07 1991-01-01 Utah State University Foundation Bacterial extract vaccines for veterinary application
US5554372A (en) 1986-09-22 1996-09-10 Emory University Methods and vaccines comprising surface-active copolymers
US5292869A (en) 1989-04-27 1994-03-08 The Board Of Governors Of The University Method for isolating and purifying transferrin and lactoferrin receptor proteins from bacteria and the preparation of vaccines containing the same
US5830479A (en) 1994-02-09 1998-11-03 Willmar Poultry Company, Inc. Active immunization using a siderophore receptor protein
ES2279511T3 (es) 1994-02-09 2007-08-16 Epitopix Llc Inmunizacion activa utilizando una proteina receptor de sideroforo.
US5538733A (en) 1994-07-07 1996-07-23 Willmar Poultry Company, Inc. Method of priming an immune response in a one-day old animal
US6403337B1 (en) 1996-01-05 2002-06-11 Human Genome Sciences, Inc. Staphylococcus aureus genes and polypeptides
AU3126097A (en) 1996-05-16 1997-12-05 The Texas A & M University System Collagen binding protein compositions and methods of use
US6680195B1 (en) 1997-11-26 2004-01-20 Inhibitex, Inc. Extracellular matrix-binding proteins from staphylococcus aureus
US6703025B1 (en) 1998-08-31 2004-03-09 Inhibitex, Inc. Multicomponent vaccines
US6692739B1 (en) 1998-08-31 2004-02-17 Inhibitex, Inc. Staphylococcal immunotherapeutics via donor selection and donor stimulation
US6682754B2 (en) 1999-11-24 2004-01-27 Willmar Poultry Company, Inc. Ovo delivery of an immunogen containing implant
US20020061569A1 (en) * 2000-03-21 2002-05-23 Robert Haselbeck Identification of essential genes in prokaryotes
AT410173B (de) 2000-06-08 2003-02-25 Cistem Biotechnologies Gmbh Antigene zusammensetzung
BR0206293B1 (pt) 2001-01-03 2015-01-20 Epitopix Llc “composições compreendendo polipeptídeos receptores de sideróforos e porinas de micróbio gram-negativo, bem como métodos de isolar polipeptídeos de membrana externa
AT410798B (de) * 2001-01-26 2003-07-25 Cistem Biotechnologies Gmbh Verfahren zur identifizierung, isolierung und herstellung von antigenen gegen ein spezifisches pathogen
EP2339344A1 (en) 2001-06-15 2011-06-29 Inhibitex, Inc. Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus
WO2003020875A2 (en) 2001-06-17 2003-03-13 D-Squared Biotechnologies, Inc. Staphylococci surface-exposed immunogenic polypeptides
US6720160B2 (en) 2001-10-11 2004-04-13 Helica Biosystems, Inc. Method for simultaneous detection of multiple microbial antigens in biological specimens from mastitic animals
AU2003254555A1 (en) 2002-07-26 2004-02-23 Intercell Ag S. aureus antigene
BRPI0414267A (pt) 2003-09-19 2006-11-21 Epitopix Llc polipeptìdeos de campilobacter e métodos de uso
EP1740604A2 (en) 2004-04-27 2007-01-10 Intercell AG Td antigens
CA2576247C (en) 2004-08-26 2016-08-30 The University Of Western Ontario Pharmaceutical compositions comprising inhibitors of iron transport, and method of identifying iron transport inhibitors, in staphylococcus aureus
KR20070085457A (ko) * 2004-10-25 2007-08-27 더 유니버시티 오브 웨스턴 온타리오 스태필로코쿠스 아우레우스의 철에 의해 조절되는 표면결정인자 ＩｓｄＡ, ＩｓｄＢ, 및 ＩｓｄＣ 기재 백신,조성물 및 방법
US8021885B2 (en) 2006-10-11 2011-09-20 Evonik Rohmax Additives Gmbh Method for the determination of the oxidative stability of a lubricating fluid
BRPI1011856A2 (pt) 2009-03-23 2020-11-03 Epitopix, Llc polipeptídeos e composições de imunização contendo polipeptídeos gram-positivos e métodos de uso

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060115490A1 (en) 2001-03-27 2006-06-01 Vega Masignani Staphylococcus aureus proteins and nucleic acids
US20080200650A1 (en) 2005-02-14 2008-08-21 Epitopix, Llc Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use

Also Published As

Publication number Publication date
KR101770321B1 (ko) 2017-09-05
AU2010229498A1 (en) 2011-10-13
CN105582524A (zh) 2016-05-18
EP2411046A4 (en) 2012-09-19
IL215330A0 (en) 2011-12-29
MX339461B (es) 2016-05-27
WO2010111273A1 (en) 2010-09-30
US9932373B2 (en) 2018-04-03
JP6092933B2 (ja) 2017-03-08
CN102448489A (zh) 2012-05-09
NZ595231A (en) 2014-03-28
US20120034258A1 (en) 2012-02-09
JP2015164949A (ja) 2015-09-17
EP2411046B1 (en) 2017-12-06
KR20120005471A (ko) 2012-01-16
AR075933A1 (es) 2011-05-04
IL215330A (en) 2016-12-29
ZA201106959B (en) 2012-06-27
IL248523A0 (en) 2016-12-29
EP2411046A1 (en) 2012-02-01
NZ614557A (en) 2015-03-27
US20180237481A1 (en) 2018-08-23
KR20150093774A (ko) 2015-08-18
MX2011009949A (es) 2011-10-06
JP2012521441A (ja) 2012-09-13
AU2016201992A1 (en) 2016-04-21
CA2756313A1 (en) 2010-09-30
BRPI1011856A2 (pt) 2020-11-03
AU2016201992B2 (en) 2018-02-15
KR20160064237A (ko) 2016-06-07
KR20160114744A (ko) 2016-10-05

Similar Documents

Publication Publication Date Title
US9981028B2 (en) Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use
AU2016201992B2 (en) Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use
AU2010229498B2 (en) Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use
CN102448489B (zh) 多肽和含有革兰氏阳性多肽的免疫组合物及使用方法
AU2015258239B2 (en) Polypeptides from staphylococcus aureus and methods of use
AU2012244060B2 (en) Polypeptides from staphylococcus aureus and methods of use

Legal Events

Date Code Title Description
A107 Divisional application of patent
PA0104 Divisional application for international application

St.27 status event code: A-0-1-A10-A16-div-PA0104

St.27 status event code: A-0-1-A10-A18-div-PA0104

A201 Request for examination
AMND Amendment
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

E601 Decision to refuse application
PE0601 Decision on rejection of patent

St.27 status event code: N-2-6-B10-B15-exm-PE0601

X091 Application refused [patent]
T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

A107 Divisional application of patent
AMND Amendment
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0104 Divisional application for international application

St.27 status event code: A-0-1-A10-A16-div-PA0104

St.27 status event code: A-0-1-A10-A18-div-PA0104

PX0901 Re-examination

St.27 status event code: A-2-3-E10-E12-rex-PX0901

PX0701 Decision of registration after re-examination

St.27 status event code: A-3-4-F10-F13-rex-PX0701

X701 Decision to grant (after re-examination)
GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

Fee payment year number: 1

St.27 status event code: A-2-2-U10-U12-oth-PR1002

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

P22-X000 Classification modified

St.27 status event code: A-4-4-P10-P22-nap-X000

FPAY Annual fee payment

Payment date: 20191126

Year of fee payment: 4

PR1001 Payment of annual fee

Fee payment year number: 4

St.27 status event code: A-4-4-U10-U11-oth-PR1001

PC1903 Unpaid annual fee

Not in force date: 20201203

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

St.27 status event code: A-4-4-U10-U13-oth-PC1903

PC1903 Unpaid annual fee

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20201203

St.27 status event code: N-4-6-H10-H13-oth-PC1903